52 results
8-K
EX-10.1
RCKT
Rocket Pharmaceuticals Inc
11 Feb 20
Rocket Pharmaceuticals Announces Private Exchange Transactions Regarding Outstanding Convertible Senior Notes due 2021
5:26pm
such holder’s hedging activities in connection with the Exchange at a price per share of $23.89 (the “Repurchase Consideration”) (the “Privately-Negotiated … with commercially reasonable hedging transactions in connection with the Exchange.
(d) This Exchange Agreement and the consummation of the transactions
425
EX-99.1
RCOR
Renovacor Inc
20 Sep 22
Business combination disclosure
4:58pm
to (or otherwise enters into a hedging arrangement with respect to), transfers, tenders or disposes (by merger, by testamentary disposition
8-K
EX-99.1
RCKT
Rocket Pharmaceuticals Inc
20 Sep 22
Entry into a Material Definitive Agreement
4:52pm
to (or otherwise enters into a hedging arrangement with respect to), transfers, tenders or disposes (by merger, by testamentary disposition
425
EX-99.2
RCOR
Renovacor Inc
20 Sep 22
Business combination disclosure
4:58pm
, hypothecates, assigns, loans, grants an option with respect to (or otherwise enters into a hedging arrangement with respect to), transfers, tenders
8-K
EX-99.2
RCKT
Rocket Pharmaceuticals Inc
20 Sep 22
Entry into a Material Definitive Agreement
4:52pm
, hypothecates, assigns, loans, grants an option with respect to (or otherwise enters into a hedging arrangement with respect to), transfers, tenders
10-K
EX-10.11
lofbgo47 zt
31 Mar 15
Annual report
12:00am
10-K
EX-10.10
6tt1nacgtul83
31 Mar 15
Annual report
12:00am